Answers are grounded in this paper and cite their sources.
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) was defined in the 2008 World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissue as a malignant proliferation of blastic plasmacytoid dendritic cells.1 The skin lesions appear as bruiselike erythematous nodules or tumors and are usually found already at presentation. BPDCN is highly malignant, with a mean survival time of 15.2 months.2 Data are limited concerning patients with localized skin-limited BPDCN (LS-BPDCN).
No takes yet. Share an insight, caveat, or question.
Amitay‐Laish et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: